Skip to main content
Download PDF

Macrophage Notch1 inhibits TAK1 function and RIPK3-mediated hepatocyte necroptosis through activation of β-catenin signaling in liver ischemia and reperfusion injury

Cell Communication and Signaling volume 20, Article number: 144 (2022) Cite this article

Abstract

Background

Notch signaling is highly conserved and critically involved in cell differentiation, immunity, and survival. Activation of the Notch pathway modulates immune cell functions during the inflammatory response. However, it remains unknown whether and how the macrophage Notch1 may control the innate immune signaling TAK1, and RIPK3-mediated hepatocyte necroptosis in liver ischemia and reperfusion injury (IRI). This study investigated the molecular mechanisms of macrophage Notch1 in modulating TAK1-mediated innate immune responses and RIPK3 functions in liver IRI.

Methods

Myeloid-specific Notch1 knockout (Notch1M−KO) and floxed Notch1 (Notch1FL/FL) mice (n = 6/group) were subjected to 90 min partial liver warm ischemia followed by 6 h of reperfusion. In a parallel in vitro study, bone marrow-derived macrophages (BMMs) were isolated from these conditional knockout mice and transfected with CRISPR/Cas9-mediated β-catenin knockout (KO) vector followed by LPS (100 ng/ml) stimulation.

Results

IR stress-induced Notch1 activation evidenced by increased nuclear Notch intracellular domain (NICD) expression in liver macrophages. Myeloid Notch1 deficiency exacerbated IR-induced liver damage, with increased serum ALT levels, macrophage/neutrophil accumulation, and proinflammatory cytokines/chemokines production compared to the Notch1FL/FL controls. Unlike in the Notch1FL/FL controls, Notch1M−KO enhanced TRAF6, TAK1, NF-κB, RIPK3, and MLKL but reduced β-catenin activation in ischemic livers. However, adoptive transfer of lentivirus β-catenin-modified macrophages markedly improved liver function with reduced TRAF6, p-TAK1, RIPK3 and p-MLKL in IR-challenged livers. Moreover, disruption of RIPK3 in Notch1M−KO mice with an in vivo mannose-mediated RIPK3 siRNA delivery system diminished IR-triggered hepatocyte death. In vitro studies showed that macrophage NICD and β-catenin co-localized in the nucleus, whereby β-catenin interacted with NICD in response to LPS stimulation. Disruption of β-catenin with a CRISPR/Cas9-mediated β-catenin KO in Notch1FL/FL macrophage augmented TRAF6 activation leading to enhanced TAK1 function. While CRISPR/Cas9-mediated TRAF6 KO in Notch1M−KO macrophage inhibited RIPK3-mediated hepatocyte necroptosis after co-culture with primary hepatocytes.

Conclusions

Macrophage Notch1 controls TAK1-mediated innate immune responses and RIPK3-mediated hepatocyte necroptosis through activation of β-catenin. β-catenin is required for the macrophage Notch1-mediated immune regulation in liver IRI. Our findings demonstrate that the macrophage Notch1-β-catenin axis is a crucial regulatory mechanism in IR-triggered liver inflammation and provide novel therapeutic potential in organ IRI and transplant recipients.

Video abstract

Background

Liver ischemia and reperfusion injury (IRI) is one of the staple causes of hepatic dysfunction or failure in liver transplants [1, 2]. Liver inflammation induced by IRI involves oxidative stress and endoplasmic reticulum (ER) stress-mediated inflammatory responses [3, 4]. Liver macrophages are the key components of the hepatic innate immune system. Liver IRI activates liver macrophage cells and promotes the generation of reactive oxygen species (ROS) and cytokines, such as IL-6 and TNF-α. By recognizing exogenous danger signals containing pathogen-derived molecular patterns (PAMPs) or endogenous molecules damage-associated molecular patterns (DAMPs) that are released from ruptured cells in inflammation, sterile inflammatory responses are activated [4, 5].

Four Notch receptors and five Notch ligands containing Jagged1, Jagged2, DLL1, DLL3, and DLL4 have been reported [6]. The Notch intracellular domain (NICD) is released when Jagged1 proteins bind to the Notch extracellular domain inducing proteolytic cleavage. Jagged1 (JAG1) plays a crucial role in the cell development process. Notch1 and JAG1 ligand Overexpression can improve cell survival in liver regeneration [7]. Furthermore, Notch signaling mediates the homeostasis of innate immune [8, 9]. Inhibition of the RBP-J promotes cell death and inflammatory injury, inducing increased inflammatory injury [10]. Although Notch signaling is proved to relate with hepatocellular protection in liver inflammation, further underlying mechanism containing Notch signaling and liver inflammatory responses need to be elucidated.

Transforming growth factor β-activated kinase1 (TAK1) plays a critical role in the process of cellular inflammatory pathways [11]. For instance, in TNF-α and Toll-like receptor (TLR) ligand pathways, TAK1 is recruited by K63 ubiquitination chain-modified signaling complexes to promote its activation [12]. TAK1 is activated to phosphorylate the downstream components such as JNK, p38, and ERK to stimulate NF-κB and MAPK pathways [13]. TAK1 deficiency in hepatocytes and cholangiocytes leads to liver cell death, inflammation, fibrosis, and HCC [14]. In addition, TAK1 liver deficiency in mice presents similarity to the gene-expression signature of human HCC. However, the crosstalk between Notch1 and TAK1 remains unknown in liver IRI.

Receptor-interacting serine/threonine-protein kinase 3(RIPK3) and its downstream molecule mixed-lineage kinase domain like protein (MLKL) have been strongly proved to mediate necroptosis, an essential form of programmed cell death [15]. On activation, RIPK3 phosphorylates MLKL, which plays a critical role in necroptosis. Necroptosis is highly immunogenic and may contribute to inflammation and carcinogenesis when sustained. RIPK3-dependent hepatocyte necroptosis is activated in IRI liver, but the particular role of RIPK3-dependent signaling in innate immune response remains elusive. In this study, we for the first time investigated the roles and molecular mechanisms of macrophage Notch1 in modulating TAK1-mediated innate immune responses and RIPK3 functions in liver IRI.

Methods

Animals

The Notch1M−KO mice were generated as described [9]. A standard protocol was used to perform mouse genotyping with primers shown in the JAX Genotyping protocols database. All animal studies were approved by the Institutional Animal Care and Use Committees of Renji Hospital and Shanghai Jiaotong University.

Mouse liver IRI model

An established model of mice 70% warm hepatic ischemia (90 min) followed by reperfusion (6 h) was used [9, 16]. Some mice have been injected with the bone marrow-derived macrophages (BMMs, 5 × 106 cells in PBS/mouse) transfected with lentivirus-expressing β-catenin (Lv-β-catenin) or control lentivirus (GFP) via the tail vein 24 h before ischemia. Some mice were injected with RIPK3 siRNAs or non-specific (NS) control siRNA (2 mg/kg) (Santa Cruz Biotechnology, Santa Cruz, CA) mixed with mannose-conjugated polymers (Polyplus transfection™, Illkirch, France) according to the manufacturer’s instructions 4 h before ischemia.

Hepatocellular function assay

The serum alanine aminotransferase (sALT) and aspartate aminotransferase (AST) were measured by ALT and AST kit (ThermoFisher, Waltham, MA) according to the manufacturer’s instructions.

Histology, immunohistochemistry, and immunofluorescence staining

The paraffin-embedded liver sections (5-μm) were stained with hematoxylin and eosin (H&E). The Suzuki’s criteria were used to grade the severity of IRI [17]. Liver macrophages were indicated by primary CD11b + rat monoclonal antibodies (mAb) using immunofluorescence staining, and the neutrophils were measured using primary Ly6G rat mAb (Invitrogen, San Diego, CA) by immunohistochemistry (IHC) staining. The RIPK3 in the mice liver was detected by IHC using RIPK3 mAb (Abcam, Cambridge, MA). The primary mouse NICD (Santa Cruz Biotechnology) mAb and rabbit β-catenin (Cell Signaling Technology) mAb were used for the double immunofluorescence staining according to the manufacturer’s instructions. Images for immunofluorescence staining were captured using a fluorescence microscope (Keyence BZ-X810, Osaka, Japan) and analyzed using Image-pro Plus software. Positive cells were counted blindly in 10 HPF/section (× 200).

Real-time reverse transcription-PCR

The RT-PCR was performed as described [18]. Total RNA was purified from liver tissue or cell cultures using RNeasy Mini Kit (Qiagen, Chatsworth, CA) according to the manufacturer’s instructions. Quantitative real-time PCR was carried out using the QuantStudio 3 (Applied Biosystems by ThermoFisher Scientific). The following were added in the final reaction volume of 25 μl: 1 × SuperMix (Platinum SYBR Green qPCR Kit; Invitrogen) cDNA and 10 μM of each primer. Amplification conditions were: 50 °C (2 min), 95 °C (5 min), followed by 40 cycles of 95 °C (15 s) and 60 °C (30 s). Primer sequences used to amplify TNF-α, IL-1β, CCL-2, and CXCL-10 were shown in Additional file 2: Table S1.

Western blot analysis

Protein was extracted from liver tissue or cell cultures as described [19]. The NICD, Bax, Bcl-2, c-caspase-3, TRAF6, p-TAK1 (Ser412), TAK1, p-P65 (Ser536), P65, RIPK3, p-MLKL (Ser345), Lamin B2, β-actin (Cell Signaling Technology) were used. The Western ECL substrate mixture (Bio-Rad) was used to image with the iBright FL1000 (ThermoFisher Scientific). See Additional file 1: Materials.

Statistical analysis

Data are expressed as mean ± SD and analyzed by Permutation t-test and Pearson correlation. Per comparison, two-sided p values less than 0.05 were considered statistically significant. Multiple group comparisons were made using one-way ANOVA followed by Bonferroni’s post hoc test. When groups showed unequal variances, we applied Welch’s ANOVA to make multiple group comparisons. All analyses were used by SAS/STAT software, version 9.4.

Additional materials and methods are included in supplemental materials and methods.

Results

Disruption of myeloid-specific Notch1 aggravates IR-induced liver injury and increases macrophage accumulation and proinflammatory mediators in IR-stressed liver

The myeloid-specific Notch1-deficient (Notch1M−KO), Notch1-proficient (Notch1FL/FL), and WT mice were subjected to 90 min of warm ischemia followed by 6 h of reperfusion. The liver macrophages were isolated from WT groups. First, we found that IR stress-induced increased nuclear Notch intracellular domain (NICD) in liver macrophages (Fig. 1A). The Notch1M−KO livers showed severe edema, sinusoidal congestion, and necrosis than the Notch1FL/FL livers, which showed mild to moderate edema, sinusoidal congestion, and narrow hepatocellular necrosis (Fig. 1B). The liver damage was evaluated by Suzuki’s histological grading of liver IRI. The hepatocellular functions are measured by the serum ALT (sALT) levels (IU/L). Myeloid Notch1 deficiency significantly augmented sALT levels at 6 h post-liver reperfusion in the Notch1M−KO mice compared to the Notch1FL/FL controls (Fig. 1C). Moreover, the Notch1M−KO ischemic livers showed increased accumulation of CD11b+ macrophages (Fig. 1D), accompanied by elevated mRNA levels coding for TNF-α, IL-1β, CCL-2, and CXCL-10 in ischemic livers (Fig. 1E), compared to the Notch1FL/FL controls. These results suggest that the Notch1 pathway plays a critical role in IR stress-induced liver inflammation and injury.

Fig. 1
figure 1

Disruption of myeloid-specific Notch1 aggravates IR-induced liver injury and increases macrophage accumulation and proinflammatory mediators in IR-stressed liver. The Notch1FL/FL, Notch1M−KO and WT mice were subjected to 90 min of partial liver warm ischemia, followed by 6 h of reperfusion. A The nuclear NICD expression was detected in liver macrophage cells from IR-stressed livers by Western blot assay. Representative of three experiments. B Representative histological staining (H&E) of ischemic liver tissue (n = 4–6 mice/group) and Suzuki’s histological score. Scale bars, 200 μm. C Liver function in serum samples was evaluated by serum ALT levels (IU/L) (n = 4–6 samples/group). D Immunohistochemistry staining of CD11b+ macrophages in ischemic livers (n = 4–6 mice/group). Quantification of CD11b+ macrophages, Scale bars, 40 μm. E Quantitative RT-PCR analysis of TNF-α, IL-1β, CCL-2 and CXCL-10 mRNA levels in ischemic livers (n = 3–4 samples/group). All data represent the mean ± SD. *p < 0.05. **p < 0.01

Full size image

Disruption of myeloid-specific Notch1 exacerbates IR-triggered hepatocyte death

The myeloid-specific Notch1-deficient (Notch1M−KO) and Notch1-proficient (Notch1FL/FL) mice were subjected to 90 min of warm ischemia followed by 6 h of reperfusion. Immunofluorescence staining revealed increased TUNEL+ hepatocytes in Notch1M−KO mice compared to Notch1FL/FL group after IR injury (Fig. 2A). The expression of Bax and cleaved-caspase3 were remarkably increased in Notch1M−KO mice, accompanied by the down-regulated level of Bcl-2 in ischemic livers (Fig. 2B). Similarly, immunohistochemistry staining of cleaved caspase-3 showed increased positive cells counts in Notch1M−KO mice (Fig. 2C). In addition, knockout of myeloid Notch1 in mice down-regulated level of β-catenin, while up-regulated the TRAF6, p-TAK1, p-P65, RIPK3, and p-MLKL expression (Fig. 2D), along with the enhanced level of RIPK3 using immunohistochemistry staining after IR injury (Fig. 2E). These results indicate that disruption of myeloid-specific Notch1 exacerbates IR-triggered hepatocyte death.

Fig. 2
figure 2

Disruption of myeloid-specific Notch1 exacerbates IR-triggered hepatocyte death. The Notch1FL/FL and Notch1M−KO mice were subjected to 90 min of partial liver warm ischemia, followed by 6 h of reperfusion. A TUNEL staining in ischemic livers (n = 4–6 mice/group). Scale bars, 100 μm. B Western blot analysis of Bax, Bcl-2, and cleaved caspase-3. Representative of three experiments. C Immunohistochemistry staining of cleaved caspase-3 in ischemic livers (n = 4–6 mice/group). Quantification of c-caspase3 positive cells, Scale bars, 40 μm. D Western blot analysis of TRAF6, p-TAK1, p-P65, RIPK3 and p-MLKL in Notch1FL/FL and Notch1M−KO mice. Representative of three experiments. E Immunohistochemistry staining of RIPK3 in ischemic livers (n = 4–6 mice/group). Scale bars, 40 μm. All data represent the mean ± SD. **p < 0.01

Full size image

β-catenin is essential for the macrophage Notch1-mediated inflammatory response in liver IRI

To investigate the role of β-catenin in macrophage Notch1-mediated immune regulation in IR-stressed liver, an adoptive transfer of lentivirus β-catenin-modified or control lentivirus-modified macrophages was constructed. As expected, lentivirus β-catenin treatment increased β-catenin expression and reduced TRAF6, p-TAK1, and p-P65 expression in isolated BMMs (Additional file 3: Fig. S1A). The mRNA levels of TNF-α, IL-1β, CCL-2, and CXCL-10 were inhibited after the overexpression of β-catenin in BMM cultures (Additional file 3: Fig. S1B). Interestingly, overexpression of β-catenin in the Notch1M−KO mice alleviated IR-induced liver damage evidenced by decreased Suzuki’s histological score (Fig. 3A) and sALT and sAST levels (Fig. 3B), compared to the control group. Moreover, lentivirus β-catenin treatment in the Notch1M−KO ischemic livers reduced CD11b+ macrophage (Fig. 3C) and Ly6G+ neutrophil (Fig. 3D) accumulation. The mRNA levels of TNF-α, IL-1β, CCL-2, and CXCL-10 in Notch1M−KO ischemic livers were also inhibited after the overexpression of β-catenin in macrophage (Fig. 3E). Unlike the control group, lentivirus β-catenin treatment reduced TRAF6, p-TAK1, and p-P65 expression (Fig. 3F) in the Notch1M−KO livers. These results demonstrate that β-catenin is a crucial regulator of Notch1-mediated inflammatory response in IR-stress livers.

Fig. 3
figure 3

β-catenin is essential for the macrophage Notch1-mediated inflammatory response in liver IRI. The Notch1M−KO mice were injected via tail vein with bone marrow-derived macrophages (BMMs, 5 × 106 cells/mouse) transfected with lentivirus expressing β-catenin (Lv-β-catenin) or GFP control (Lv-GFP) 24 h prior to ischemia. A Representative histological staining (H&E) of ischemic liver tissue (n = 4–6 mice/group) and Suzuki’s histological score. Scale bars, 200 μm. B Liver function in serum samples was evaluated by serum ALT and AST levels (IU/L) (n = 4–6 samples/group). C Immunofluorescence staining of CD11b+ macrophages in ischemic livers (n = 4–6 mice/group). Quantification of CD11b+ macrophages, Scale bars, 40 μm. D Immunohistochemistry staining of Ly6G+ neutrophils in ischemic livers (n = 4–6 mice/group). Quantification of Ly6G+ neutrophils, Scale bars, 40 μm. E Quantitative RT-PCR analysis of TNF-α, IL-1β, CCL-2 and CXCL-10 mRNA levels in ischemic livers (n = 3–4 samples/group). F Western blot analysis and relative density ratio of TRAF6, p-TAK1, and p-P65. Representative of three experiments. All data represent the mean ± SD. *p < 0.05. **p < 0.01

Full size image

Myeloid Notch1 signaling controls immune regulation and hepatocyte death in a RIPK3-dependent manner in IR-stressed liver

Having found that the RIPK3 functions were augmented in Notch1M−KO mice in liver IRI, we then examined whether RIPK3 is essential in liver inflammation and cellular injury in Notch1-mediated IR-stressed livers. We disrupted RIPK3 in Notch1M−KO livers with an in vivo mannose-mediated RIPK3 siRNA delivery system that delivers explicitly to macrophages by expressing a mannose-specific membrane receptor as previously described [20]. The efficacy of in-vivo RIPK3 inhibition was confirmed by immunoblot in Additional file 4: Figure S2A. Unlike the administration of non-specific (NS) siRNA in the Notch1M−KO mice, the knockdown of RIPK3 significantly (p < 0.05) decreased IR-induced liver damage (Fig. 4A) and the sALT and sAST levels (Fig. 4B) in the Notch1M−KO mice. RIPK3 siRNA treatment in the Notch1M−KO livers reduced CD11b+ macrophage (Fig. 4C) and Ly6G neutrophil (Fig. 4D) accumulation. Moreover, RIPK3 knockdown decreased mRNA levels of TNF-α, IL-1β, CCL-2, and CXCL-10 in Notch1 myeloid knockout mice (Fig. 4E). Notably, RIPK3 siRNA treatment alleviated hepatocyte apoptosis/necroptosis/necrosis evidenced by decreased TUNEL+ cells in IR-stressed livers compared to the NS siRNA-treated livers (Fig. 4F). These results demonstrate RIPK3 plays a critical role in the Notch1-mediated immune regulation and hepatocyte apoptosis/ necroptosis/ necrosis in IRI livers.

Fig. 4
figure 4

Myeloid Notch1 signaling controls immune regulation and hepatocyte necroptosis in a RIPK3-dependent manner in IR-stressed liver. The Notch1M−KO mice were injected via tail vein with RIPK3 siRNA (2 mg/kg) or non-specific (NS) control siRNA mixed with mannose-conjugated polymers at 4 h prior to ischemia. A Representative histological staining (H&E) of ischemic liver tissue (n = 4–6 mice/group) and Suzuki’s histological score. Scale bars, 200 μm. B Liver function in serum samples was evaluated by serum ALT and AST levels (IU/L) (n = 4–6 samples/group). C Immunofluorescence staining of CD11b+ macrophages in ischemic livers (n = 4–6 mice/group). Quantification of CD11b+ macrophages, Scale bars, 40 μm. D Immunohistochemistry staining of Ly6G+ neutrophils in ischemic livers (n = 4–6 mice/group). Quantification of Ly6G+ neutrophils, Scale bars, 100 μm. E Quantitative RT-PCR analysis of TNF-α, IL-1β, CCL-2 and CXCL-10 mRNA levels in ischemic livers (n = 3–4 samples/group). F TUNEL staining in ischemic livers (n = 4–6 mice/group). Results were scored semi-quantitatively by averaging the number of necroptotic cells. All data represent the mean ± SD. *p < 0.05. **p < 0.01

Full size image

β-catenin interacts with NICD and mediates TAK1 activation in macrophages

Having demonstrated that β-catenin is a key regulator of Notch1-mediated inflammatory response in IR-stress livers, we then analyzed putative crosstalk between β-catenin and the TAK1 pathway in macrophages. Interestingly, Immunofluorescence staining revealed that β-catenin co-localized with NICD in LPS-stimulated BMMs (Fig. 5A). The co-immunoprecipitation assay revealed β-catenin could directly bound to endogenous NICD in BMMs after LPS stimulation (Fig. 5B). To further confirm that β-catenin is required for the crosstalk between Notch1 and TAK1-mediated innate immune responses in vitro, we introduced CRISPR/Cas9. Strikingly, CRISPR/Cas9-mediated β-catenin activation reduced TRAF6, p-TAK1, and p-P65 expression (Fig. 5C) in macrophages from Notch1M−KO mice. Similarly, CRISPR/Cas9-mediated β-catenin KO increased TRAF6, p-TAK1, and p-P65 expression (Fig. 5D) in macrophages from Notch1FL/FL mice. These results indicate that β-catenin interacts with NICD and controls the crosstalk between Notch1 and TAK1-mediated innate immune responses.

Fig. 5
figure 5

β-catenin interacts with NICD and mediates TAK1 activation in macrophages. Bone marrow-derived macrophages (BMMs, 1 × 106) were cultured with or without LPS (100 ng/ml) for 6 h. A Immunofluorescence staining for macrophage β-catenin (green) and NICD (red) co-localization in LPS-stimulated macrophages. DAPI was used to visualize nuclei (blue). Scale bars, 30 μm. B Immunoprecipitation analysis of β-catenin and NICD in LPS-stimulated macrophages. C Western blot analysis of β-catenin, TRAF6, p-TAK1 and p-P65 in BMMs transfected with CRISPR/Cas9-mediated β-catenin activation and control. Representative of three experiments. D Western blot analysis of β-catenin, TRAF6, p-TAK1 and p-P65 in BMMs transfected with CRISPR/Cas9-mediated β-catenin KO and control. Representative of three experiments

Full size image

TRAF6 is essential for the Notch1-mediated inflammatory response and ROS generation in LPS-stimulated macrophages

To further confirm the role of TRAF6 in the regulation of macrophage Notch1-mediated immune responses in IR-stressed liver, BMMs were isolated from the Notch1FL/FL and Notch1M−KO mice and transfected with CRISPR/Cas9-mediated TRAF6 activation or TRAF6 KO vector. Indeed, CRISPR/Cas9-mediated TRAF6 activation increased p-TAK1 and p-P65 expression in Notch1FL/FL macrophages (Fig. 6A), along with augmented mRNA levels coding for TNF-α, IL-1β, CCL-2, and CXCL-10 (Fig. 6B) in Notch1FL/FL macrophages after LPS-stimulation. ROS production presented by Carboxy-H2DFFDA showed enhanced ROS generation in CRISPR-TRAF6 activation macrophages (Fig. 6C). Moreover, CRISPR/Cas9-mediated TRAF6 KO diminished p-TAK1 and p-P65 expression (Fig. 6D). The mRNA levels coding for TNF-α, IL-1β, CCL-2, and CXCL-10 were also reduced (Fig. 6E), accompanied by down-regulated ROS production in Notch1M−KO macrophages after LPS-stimulation (Fig. 6F). These results indicate that TRAF6 is critically involved in activating TAK1-mediated inflammatory responses.

Fig. 6
figure 6

TRAF6 is essential for the Notch1-mediated inflammatory response and ROS generation in LPS-stimulated macrophages. BMMs were isolated from the Notch1FL/FL and Notch1M−KO mice and transfected with CRISPR/Cas9-mediated TRAF6 activation or TRAF6 KO vector. A Western blot analysis of TRAF6, p-TAK1 and p-P65 in BMMs transfected with CRISPR/Cas9-mediated TRAF6 activation and control. Representative of three experiments. B Quantitative RT-PCR analysis of TNF-α, IL-1β, CCL-2 and CXCL-10 mRNA levels in vitro (n = 3–4 samples/group). C Detection of ROS production by Carboxy-H2DFFDA in LPS-stimulated macrophages from the Notch1FL/FL mice. Quantification of ROS-producing Macrophages (green) (n = 4–6 mice/group). Scale bars, 40 μm. D Western blot analysis of TRAF6, p-TAK1 and p-P65 in BMMs transfected with CRISPR/Cas9-mediated TRAF6 KO and control. Representative of three experiments. E Quantitative RT-PCR analysis of TNF-α, IL-1β, CCL-2 and CXCL-10 mRNA levels in vitro (n = 3–4 samples/group). F Detection of ROS production by Carboxy-H2DFFDA in LPS-stimulated macrophages from the Notch1M−KO mice. Quantification of ROS-producing Macrophages (green) (n = 4–6 mice/group). Scale bars, 40 μm. All data represent the mean ± SD. *p < 0.05. **p < 0.01. ***p < 0.001

Full size image

Macrophage Notch1 deficiency-mediated TRAF6 enhances stress-induced hepatocyte necroptosis via modulating RIPK3 signaling activation

We then asked how macrophage TRAF6 may regulate hepatocyte necroptosis under inflammatory conditions. Using a co-culture system with LPS-stimulated CRISPR-TRAF6 KO BMMs from the Notch1M−KO mice and primary hepatocytes isolated from WT mice supplemented with H2O2 (Fig. 7A), we found decreased TNF-α release from LPS-stimulated Notch1M−KO BMMs after transfection with a CRISPR-TRAF6 KO vector compared to the control groups (Fig. 7B). Moreover, our results showed that the LDH released from stressed hepatocytes was markedly inhibited in the macrophage TRAF6 KO group (Fig. 7C). Unlike the control groups, macrophage TRAF6 KO decreased hepatocyte p-MLKL and RIPK3 expression (Fig. 7D). Strikingly, Immunofluorescence staining revealed reduced TUNEL+ hepatocytes after co-culture with the CRISPR-TRAF6 KO BMMs but not the control cells (Fig. 7E). These results indicate that macrophage TRAF6 deficiency diminishes hepatocyte necroptosis by inhibiting RIPK3-pMLKL signaling in response to inflammatory responses.

Fig. 7
figure 7

Macrophage Notch1 deficiency-mediated TRAF6 enhances stress-induced hepatocyte necroptosis via modulating RIPK3 signaling activation. BMMs were isolated from Notch1M−KO mice and transfected with the p-CRISPR-TRAF6 KO or control vector followed by LPS stimulation. A The schematic figure for macrophage/hepatocyte co-culture system. B ELISA analysis of supernatant TNF-α levels in LPS-stimulated BMMs (n = 3–4 samples/group). C LDH release from hepatocytes in co-cultures. Quantification of average cytotoxicity (% cell death) in different groups were plotted. (n = 3–4 samples/group). D BMMs transfected with the p-CRISPR-TRAF6 KO were stimulated with LPS, and then co-cultured with primary hepatocytes supplemented with or without H2O2 for 24 h. Western-assisted analysis of p-MLKL and RIPK3 in hepatocytes after co-culture. Representative of three experiments. E Immunofluorescence staining of TUNEL+ hepatocytes after co-culture (n = 4–6 mice/group). Scale bars, 40 μm. All data represent the mean ± SD. **p < 0.01

Full size image

Discussion

In this study, we revealed that disruption of macrophage Notch1 activated the TAK1-mediated inflammatory responses and RIPK3-mediated hepatocyte necroptosis through activation of β-catenin in IR stress-induced liver inflammation. In detail, we showed that macrophage Notch1 deficiency inhibited the expression of β-catenin, which led to enhanced TAK1 signaling activation and hepatocyte necroptosis in liver IRI. Our findings demonstrate the macrophage Notch1-β-catenin axis is a crucial regulatory mechanism in IR-triggered liver inflammation and provide novel therapeutic potential in organ IRI and transplant recipients.

The Notch pathway is considered as the most commonly activated pathway in the process of liver inflammatory diseases [21, 22]. As Notch signaling participates in a variety of cellular activities, the modulation of the Notch cascade has been proved to cause lots of pathological changes. For example, the stimulation of the Notch pathway by TLR4 activation may involve gene expression profiles linking with inflammatory processes [23]. Moreover, the Notch intracellular domain (NICD) inhibited proinflammatory cytokine release when expression of the anti-inflammatory regulator was stimulated in TLR-activated macrophages [24]. In addition, Notch1 and one of its target genes Hes1 might suppress the inflammation through transcriptional regulation. RhoA/ROCK signaling was stimulated in myeloid Notch1 deficient mice and aggravated liver inflammation [25]. These results implied the Notch pathway regulates inflammatory responses through multiple mechanisms. This study investigated the roles and molecular mechanisms of macrophage Notch1 in modulating TAK1-mediated innate immune responses in liver IRI. Our findings reveal a novel mechanism in which Notch1 signaling regulates the TAK1-related innate immune response and RIPK3-mediated necroptosis through β-catenin in IR-stressed livers.

TAK1 involves in many crucial processes, such as cell death, immune regulation, and carcinogenesis [26]. Previous studies have reported that the deficiency of TAK1 significantly improved energy metabolism, inflammation, fibrosis, and tumor formation [27,28,29]. on the other hand, hyperactivation of TAK1 may cause hepatic inflammation, metabolic disturbances, and fibrosis. Thus, TAK1 homeostasis is vital to liver physiological activity [25]. Our results revealed the crosstalk between TAK1-mediated innate immune responses and the Notch1 signaling pathway in liver IRI, proving that the Notch1 pathway could regulate TAK1-mediated inflammatory responses.

However, it remains unclear how Notch1 may modulate TAK1-mediated inflammatory response in IR-stressed liver. In line with our in vitro findings, we showed that lentivirus β-catenin-modified macrophages alleviated IR-induced liver damage and reduced CD11b+ macrophage and Ly6G+ neutrophil accumulation, along with the decrease of proinflammatory cytokine. Notably, using the immunofluorescence staining and co-immunoprecipitation assay, we found that β-catenin co-localized with NICD. Indeed, CRISPR/Cas9-mediated β-catenin activation reduced TRAF6, p-TAK1, and p-P65 expression in macrophages from Notch1M−KO mice, and CRISPR/Cas9-mediated β-catenin KO increased TRAF6, p-TAK1, and p-P65 expression in macrophages from Notch1FL/FL mice. Our findings revealed the distinct ability of Notch1 in controlling TAK1 function through β-catenin in IR stress-induced liver injury.

Interestingly, macrophage Notch1-mediated TRAF6 could also be involved in regulating IR-induced necroptosis pathways. IR-stress related ROS may induce RIPK3 stimulation. RIPK3 is an essential regulator in necroptosis. Through the RIP-homotypic interaction motif (RHIM), RIPK3 interacts with its upstream kinase RIPK1 to generate a necrosome, which functions as a recruitment factor of the Mixed lineage kinase domain like pseudo kinase (MLKL) [26]. Activated MLKL also causes membrane rupture. As a result, danger-associated molecular patterns (DAMPs) are released to facilitate inflammatory responses [27]. Indeed, as a critical switch for necrosis and inflammation, RIPK3 activation, which is regulated by caspase-mediated cleavage, promoted inflammation related cell death and injury in different inflammatory disease models [30]. RIPK3 deficiency alleviated liver fibrosis in a caspase-8-dependent manner by regulating JNK signaling pathway [31]. In line with these results, our precious study displayed that disruption of RIPK3 reduced caspase-1 activity by inhibiting NEK7/NLRP3 function in hepatic ischemia–reperfusion injury [32]. The present study showed that CRISPR/Cas9-mediated TRAF6 KO inhibited TNF-α release in Notch1M−KO macrophages under LPS stimulation. Using in vitro macrophage/hepatocyte co-culture system, we showed that macrophage TRAF6 deficiency decreased hepatocyte p-MLKL and RIPK3 expression, and reduced LDH release from H2O2-treated hepatocytes. In addition, immunofluorescence staining result further identified that macrophage TRAF6 deletion alleviated the hepatocyte necroptosis in H2O2-induced injury. Our findings demonstrate that macrophage Notch1 deficiency-mediated TRAF6 activation promotes hepatocyte necroptosis through modulation of RIPK3-p-MLKL initiated caspase cascade activation.

Conclusions

To sum up, we identify a previously unrecognized role of the macrophage Notch1-β-catenin axis in regulating TAK1-mediated innate immune response and RIPK3-mediated necroptosis signaling pathway in IR stress-induced liver injury. We identify that the macrophage Notch1-mediated β-catenin axis controls TAK1-dependent inflammation. By disclosing the molecular regulatory mechanism of macrophage β-catenin-mediated Notch1-TAK1 pathway in IR- stressed liver, our findings provide novel potential therapeutic targets in IRI and liver inflammation.

Availability of data and materials

The datasets generated for this study are available on request to the corresponding author.

Abbreviations

IRI:

Ischemia/reperfusion injury

sALT:

Serum alanine aminotransferase

ROS:

Reactive oxygen species

LPS:

Lipopolysaccharide

BMMs:

Bone marrow-derived macrophages

CMFDA:

5-Chloromethylfluorescein diacetate

CRISPR:

Clustered regularly interspaced short palindromic repeats

Cas9:

CRISPR associated protein 9

NICD:

Notch1 intracellular domain

PCR:

Polymerase chain reaction

TUNEL:

Terminal deoxynucleotidyl transferase dUTP nick end labelling

TAK1:

Transforming growth factor beta-activated kinase 1

WT:

Wild type

RIPK3:

Receptor-interacting serine/threonine-protein kinase 3

MLKL:

Mixed-lineage kinase domain like protein

References

  1. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32:169–73.

    Article  CAS  Google Scholar 

  2. Ito T, Naini BV, Markovic D, Aziz A, Younan S, Lu M, Hirao H, et al. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients. Am J Transplant. 2021;21:614–25.

    Article  CAS  Google Scholar 

  3. Dara L, Ji C, Kaplowitz N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology. 2011;53:1752–63.

    Article  CAS  Google Scholar 

  4. Hirao H, Nakamura K, Kupiec-Weglinski JW. Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity. Nat Rev Gastroenterol Hepatol. 2021;19:239.

    Article  Google Scholar 

  5. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev. 2007;220:60–81.

    Article  CAS  Google Scholar 

  6. Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol. 2000;228:151–65.

    Article  CAS  Google Scholar 

  7. Shimizu K, Chiba S, Saito T, Kumano K, Hirai H. Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. Biochem Biophys Res Commun. 2000;276:385–9.

    Article  CAS  Google Scholar 

  8. Dou GR, Wang YC, Hu XB, Hou LH, Wang CM, Xu JF, Wang YS, et al. RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice. Faseb J. 2008;22:1606–17.

    Article  CAS  Google Scholar 

  9. Lu L, Yue S, Jiang L, Li C, Zhu Q, Ke M, Lu H, et al. Myeloid Notch1 deficiency activates the RhoA/ROCK pathway and aggravates hepatocellular damage in mouse ischemic livers. Hepatology. 2018;67:1041–55.

    Article  CAS  Google Scholar 

  10. Wang L, Wang CM, Hou LH, Dou GR, Wang YC, Hu XB, He F, et al. Disruption of the transcription factor recombination signal-binding protein-Jkappa (RBP-J) leads to veno-occlusive disease and interfered liver regeneration in mice. Hepatology. 2009;49:268–77.

    Article  Google Scholar 

  11. Xu YR, Lei CQ. TAK1-TABs complex: a central signalosome in inflammatory responses. Front Immunol. 2020;11:608976.

    Article  CAS  Google Scholar 

  12. Adhikari A, Xu M, Chen ZJ. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene. 2007;26:3214–26.

    Article  CAS  Google Scholar 

  13. Wang X, Mao W, Fang C, Tian S, Zhu X, Yang L, Huang Z, et al. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression. J Hepatol. 2017;68:118.

    Article  Google Scholar 

  14. Inokuchi S, Aoyama T, Miura K, Osterreicher CH, Kodama Y, Miyai K, Akira S, et al. Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci USA. 2010;107:844–9.

    Article  CAS  Google Scholar 

  15. Newton K. RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol. 2015;25:347–53.

    Article  CAS  Google Scholar 

  16. Sheng M, Lin Y, Xu D, Tian Y, Zhan Y, Li C, Farmer DG, et al. CD47-mediated hedgehog/SMO/GLI1 signaling promotes mesenchymal stem cell immunomodulation in mouse liver inflammation. Hepatology. 2021;74:1560–77.

    Article  CAS  Google Scholar 

  17. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury: modulating effects of FK506 and cyclosporine. Transplantation. 1993;55:1265–72.

    Article  CAS  Google Scholar 

  18. Li C, Sheng M, Lin Y, Xu D, Tian Y, Zhan Y, Jiang L, et al. Functional crosstalk between myeloid Foxo1-β-catenin axis and Hedgehog/Gli1 signaling in oxidative stress response. Cell Death Differ. 2021;28:1705–19.

    Article  CAS  Google Scholar 

  19. Jin Y, Li C, Xu D, Zhu J, Wei S, Zhong A, Sheng M, et al. Jagged1-mediated myeloid Notch1 signaling activates HSF1/Snail and controls NLRP3 inflammasome activation in liver inflammatory injury. Cell Mol Immunol. 2020;17:1245–56.

    Article  Google Scholar 

  20. Zhang Q, Wang C, Liu Z, Liu X, Han C, Cao X, Li N. Notch signal suppresses Toll-like receptor-triggered inflammatory responses in macrophages by inhibiting extracellular signal-regulated kinase 1/2-mediated nuclear factor κB activation. J Biol Chem. 2012;287:6208–17.

    Article  CAS  Google Scholar 

  21. Shang Y, Coppo M, He T, Ning F, Yu L, Kang L, Zhang B, et al. The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation. Nat Immunol. 2016;17:930–7.

    Article  CAS  Google Scholar 

  22. Yang YM, Noureddin M, Liu C, Ohashi K, Kim SY, Ramnath D, Powell EE, et al. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis. Sci Transl Med. 2019;11:eaat9284.

    Article  CAS  Google Scholar 

  23. Totzke J, Scarneo SA, Yang KW, Haystead TAJ. TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases. Open Biol. 2020;10:200099.

    Article  CAS  Google Scholar 

  24. Tan S, Zhao J, Sun Z, Cao S, Niu K, Zhong Y, Wang H, et al. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma. Proc Natl Acad Sci USA. 2020;117:14231–42.

    Article  CAS  Google Scholar 

  25. Wang S, Yan ZZ, Yang X, An S, Zhang K, Qi Y, Zheng J, et al. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver. Hepatology. 2018;67:1320–38.

    Article  CAS  Google Scholar 

  26. Moriwaki K, Chan FK. Regulation of RIPK3- and RHIM-dependent necroptosis by the proteasome. J Biol Chem. 2016;291:5948–59.

    Article  CAS  Google Scholar 

  27. Krysko O, Aaes TL, Kagan VE, D’Herde K, Bachert C, Leybaert L, Vandenabeele P, et al. Necroptotic cell death in anti-cancer therapy. Immunol Rev. 2017;280:207–19.

    Article  CAS  Google Scholar 

  28. Liu D, Zhang P, Zhou J, Liao R, Che Y, Gao MM, Sun J, et al. TNFAIP3 interacting protein 3 overexpression suppresses nonalcoholic steatohepatitis by blocking TAK1 activation. Cell Metab. 2020;31:726-740.e728.

    Article  CAS  Google Scholar 

  29. Malireddi RKS, Gurung P, Kesavardhana S, Samir P, Burton A, Mummareddy H, Vogel P, et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. 2020;217:1.

    Article  CAS  Google Scholar 

  30. Moriwaki K, Chan FK. RIP3: a molecular switch for necrosis and inflammation. Genes Dev. 2013;27:1640–9.

    Article  CAS  Google Scholar 

  31. Gautheron J, Vucur M, Reisinger F, Cardenas DV, Roderburg C, Koppe C, Kreggenwinkel K, et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med. 2014;6:1062–74.

    Article  CAS  Google Scholar 

  32. Li C, Sheng M, Lin Y, Xu D, Tian Y, Zhan Y, Jiang L, et al. Functional crosstalk between myeloid Foxo1-β-catenin axis and Hedgehog/Gli1 signaling in oxidative stress response. Cell Death Differ. 2020;28:1705.

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to Bibo Ke at UCLA for instructive comments and for revising the English text.

Funding

This work was supported by National Natural Science Foundation of China (81500494, 81873590 and 82000616), Shanghai City Youth Science and Technology Star Project (19QA1405500 and 19YF1428200); China Postdoctoral Science Foundation (2021M692116).

Author information

Author notes

  1. Dongwei Xu, Xiaoye Qu, Yizhu Tian and Zhao Jie have contributed equally to this work

Authors and Affiliations

  1. Department of Liver Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200127, China

    Dongwei Xu, Xiaoye Qu, Zhao Jie, Zhifeng Xi, Feng Xue, Jianjun Zhu & Qiang Xia

  2. Department of General Surgery, Pukou Branch of Jiangsu Province Hospital, Nanjing Medical University, Nanjing, 211166, China

    Yizhu Tian

  3. Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China

    Xueyun Ma

Authors
  1. Dongwei Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaoye Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yizhu Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhao Jie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhifeng Xi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Feng Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xueyun Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jianjun Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Qiang Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

DX, XQ and YT: performed experiments in vitro and in vivo and analyzed the data; JZ and ZX performed the in vivo experiments; JZ and FX performed statistical analysis; XM and JJZ participated in discussion and data analysis; QX and DX designed the research and wrote the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xueyun Ma, Jianjun Zhu or Qiang Xia.

Ethics declarations

Ethics approval and consent to participate

The animal study was reviewed and approved by Renji Hospital, Shanghai Jiaotong University School of Medicine (RA-2020-014).

Consent for publication

All of the authors agree to submit this manuscript to Cell Communication and Signaling.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Supplementary Materials.

Additional file 2.

Supplementary Table 1.

Additional file 3.

Supplementary Figure1.

Additional file 4.

Supplementary Figure2.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, D., Qu, X., Tian, Y. et al. Macrophage Notch1 inhibits TAK1 function and RIPK3-mediated hepatocyte necroptosis through activation of β-catenin signaling in liver ischemia and reperfusion injury. Cell Commun Signal 20, 144 (2022). https://doi.org/10.1186/s12964-022-00901-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12964-022-00901-8

Keyword

Cell Communication and Signaling

ISSN: 1478-811X